SCHEMBL3969970

SCHEMBL3969970

COCCOc1cc2cc(Nc3cc(C)[nH]n3)nc(Cl)c2cc1OCCOC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 7/20 0.41
CYP3A4 P08684 5/20 0.41
CYP2D6 P10635 4/20 0.41
CYP1A2 P05177 2/20 0.41
SYK P43405 1/20 0.41
PIK3C3 Q8NEB9 3/20 0.40
MEN1 O00255 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
GSK3B P49841 3/20 0.38
PAK4 O96013 2/20 0.38
PLK4 O00444 1/20 0.38
JAK2 O60674 4/20 0.37
JAK3 P52333 3/20 0.37
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
ITK Q08881 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973704 0.97 AURKA (0.40) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL14520585 0.93 AURKA (0.44) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL3969454 0.91 CYP3A4 (0.41) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL3973453 0.86 SYK (0.41) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL3968154 0.86 JAK3 (0.46) PLK4JAK2JAK3JAK1TYK2
SCHEMBL3967146 0.86 AURKA (0.43) AURKAPIK3C3MEN1HTTKMT2A
SCHEMBL3968001 0.84 CYP3A4 (0.36) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL3964306 0.84 SYK (0.39) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL3967715 0.84 SYK (0.39) AURKACYP3A4CYP2D6CYP1A2SYK
SCHEMBL3974331 0.83 SYK (0.42) AURKACYP3A4CYP2D6CYP1A2SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
EP-1966190-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
WO-2007071348-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2007-06-28 WO disclosed
WO-2007071348-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179151-A1 Isoquinoline aminopyrazole derivatives CYP3A5, CYP3A43, CYP3A4 AURKA 1165/4885CYP3A4 3/4885CYP2D6 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.